Market Trends X4 Pharmaceuticals GAAP EPS of -$0.20 misses by $0.03, revenue of $1.43M beats by $0.37MBy admin8996erT0allMarch 25, 2025 X4 Pharmaceuticals press release (NASDAQ:XFOR): Q4 GAAP EPS of -$0.20 misses by $0.03. Revenue of $1.43M beats by $0.37M. Cash…
